Model Predicts Progression Risk for Rare Type of Lymphoma
FRIDAY, May 3, 2019 -- A publicly available model can identify patients with asymptomatic Waldenstr öm macroglobulinemia (AWM) at high risk for progression, according to a study published online April 16 in the Journal of Clinical Oncology. Mark... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2019 Category: Pharmaceuticals Source Type: news

Lifetime Risk for Brain Mets Up in Elderly With Three Common Cancers
FRIDAY, May 3, 2019 -- Elderly patients with lung cancer, breast cancer, or melanoma are at increased risk for brain metastases (BMs) later in life, according to a study published online May 3 in Cancer Epidemiology, Biomarkers&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2019 Category: Pharmaceuticals Source Type: news

Bb2121 CAR-T Multiple Myeloma Treatment Effective, but Benefits May Wane Bb2121 CAR-T Multiple Myeloma Treatment Effective, but Benefits May Wane
Doctors testing a chimeric antigen receptor T-cell (CAR-T) therapy against relapsed or refractory multiple myeloma say results from 33 patients show a complete response rate of 45%, although 40% of those patients with a complete response ultimately relapsed.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - May 3, 2019 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Lung cancer warning: The itchy rash you shouldn’t ignore - it could be something serious
LUNG cancer symptoms include having a cough that won ’t go away, chest pain, and unexplained weight loss. But you could also be at risk of the disease if you develop a painful and itchy rash. Should you speak to a doctor? (Source: Daily Express - Health)
Source: Daily Express - Health - May 3, 2019 Category: Consumer Health News Source Type: news

N.S. man's Stage 4 cancer is in remission after $900K treatment in Boston
It's too early to know if Stephen Saunders has been cured of non-Hodgkin lymphoma, but he's in remission thanks to a treatment not yet available in Nova Scotia. (Source: CBC | Health)
Source: CBC | Health - May 3, 2019 Category: Consumer Health News Tags: News/Canada/Nova Scotia Source Type: news

Breast Implants Linked to Cancer Can Still be Sold in U.S.: FDA
Title: Breast Implants Linked to Cancer Can Still be Sold in U.S.: FDACategory: Health NewsCreated: 5/3/2019 12:00:00 AMLast Editorial Review: 5/3/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 3, 2019 Category: Cancer & Oncology Source Type: news

Device Spots Lymphedema Early in Breast Cancer Patients, to Help Stop It
Title: Device Spots Lymphedema Early in Breast Cancer Patients, to Help Stop ItCategory: Health NewsCreated: 5/2/2019 12:00:00 AMLast Editorial Review: 5/3/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 3, 2019 Category: Cancer & Oncology Source Type: news

Red Tape Means Many Cancer Patients Get Radiation Treatments Late
Title: Red Tape Means Many Cancer Patients Get Radiation Treatments LateCategory: Health NewsCreated: 5/2/2019 12:00:00 AMLast Editorial Review: 5/3/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 3, 2019 Category: Cancer & Oncology Source Type: news

ASBrS: Less-invasive mastectomy safe for more women
A type of mastectomy that leaves the surface of the breast intact is a safe...Read more on AuntMinnie.comRelated Reading: Contrast mammo equals MRI for measuring tumor size Racial factors affect time to breast cancer treatment Breast MRI helps guide DCIS treatment Women still need breast imaging after mastectomy Breast cancer follow-up imaging varies widely (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 3, 2019 Category: Radiology Source Type: news

Watch and Wait in Rectal Cancer: Who's In and Who's Out? Watch and Wait in Rectal Cancer: Who's In and Who's Out?
The standard surgical approach for low-lying rectal cancer can result in significant morbidity. Is a non-surgical approach potentially effective?Journal of Oncology Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 3, 2019 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Cancer cells have a problem with junk RNA that makes them vulnerable
(InsideOutBio) The important role of the ADAR enzyme and junk RNA in cancer cells opens an entirely new playbook for the treatment of tumors, one that is focused on RNA rather than DNA. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 3, 2019 Category: Cancer & Oncology Source Type: news

DNA test is an effective cervical cancer screening tool for women in low-income countries
(Dartmouth-Hitchcock Medical Center) Dartmouth researchers have introduced an inexpensive DNA-based test for human papillomavirus (HPV), the cause of cervical cancer, in Honduras. The test aid can effectively be used to screen women who have never been screened for this deadly disease. Results of the initiative revealed not only high positivity rates of HPV but unexpected differences in the types of HPV compared to those found in the US. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 3, 2019 Category: International Medicine & Public Health Source Type: news

Stephenson Cancer Center physician is senior author on major study
(University of Oklahoma) A gynecologic oncologist at the Stephenson Cancer Center at OU Medicine was a national leader of a newly published research study that reveals good news for women with ovarian cancer -- longer survival times plus a treatment option that causes fewer difficult side effects. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 3, 2019 Category: International Medicine & Public Health Source Type: news

Adding the T-Cell Booster Decitabine to Anti –PD-1 Therapy in Hodgkin Lymphoma
Researchers tested the addition of the T cell –boosting decitabine to anti–PD-1 therapy with camrelizumab among patients with relapsed or refractory classic Hodgkin lymphoma. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Efficacy of One-Day Fractionated Photodynamic Therapy for Basal Cell Carcinoma
Researchers evaluated the response of patients with BCC to fractionated photodynamic therapy at 30 days after treatment. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Review Touts Benefits of Immunotherapy for Non-Melanoma Skin Cancers
The authors discuss the potential use and limitations of immunotherapy among patients with squamous cell cancer, basal cell carcinoma, and other skin cancers. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

High-Dose Vitamin D3 May Be Beneficial in Patients with Metastatic CRC
A study in JAMA evaluated whether adding high-dose vitamin D3  to standard chemotherapy improves PFS in patients with advanced or metastatic colorectal cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2019 Category: Cancer & Oncology Authors: John Schieszer Source Type: news

Making the invisible visible: New method opens unexplored realms for liquid biopsies
(Michigan Medicine - University of Michigan) A new approach to RNA sequencing reveals thousands of previously inaccessible RNA fragments in blood plasma that might serve as disease- and organ-specific biomarkers (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 3, 2019 Category: Cancer & Oncology Source Type: news

Study reveals amyloid clumps of a truncated p53 structure related to endometrial cancer
(Instituto Nacional de Ciência e Tecnologia de Biologia Estrutural e Bioimagem (INBEB)) Brazilian scientists have discovered that a truncated variant of the tumor suppressor protein p53 is present as amyloid aggregates in endometrial cancer cells. Published in the Journal of Biological Chemistry, the study points to new perspectives for treating tumors in which p53 variants are important components of these clusters, given that alterations in the p53 protein are associated with more aggressive versions of these tumors, with a high mortality rate. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 3, 2019 Category: Cancer & Oncology Source Type: news

New review identifies four hallmarks of cancer metastasis
(University of Alabama at Birmingham) Researchers at the University of Alabama at Birmingham and the University of Kansas Cancer Center have identified four hallmarks of cancer metastasis -- when cancer has spread to different parts of the body from where it started. Metastasis is believed to be the cause of up to 90 percent of cancer deaths. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 3, 2019 Category: Cancer & Oncology Source Type: news

Elderly survivors of three common cancers face persistent risk of brain metastasis
(American Association for Cancer Research) Elderly survivors of breast cancer, lung cancer, and melanoma face risk of brain metastasis later in life, and may require extra surveillance in the years following initial cancer treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 3, 2019 Category: International Medicine & Public Health Source Type: news

Seventh Annual JADPRO Live Conference for Oncology Advanced...
Advanced practitioners in oncology—clinicians on the frontlines of care—will come together October 24 to 27 in Seattle for the largest oncology conference designed to support their specific role on...(PRWeb May 03, 2019)Read the full story at https://www.prweb.com/releases/seventh_annual_jadpro_live_conference_for_oncology_advanced_practitioners_explores_innovation_in_cancer_care/prweb16279837.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 3, 2019 Category: Pharmaceuticals Source Type: news

ASTRO: Prior Authorization Obstacles Delaying Treatment
Almost all radiation oncologists report their patients are delayed from receiving life - saving treatment (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 3, 2019 Category: Cancer & Oncology Tags: Oncology, Radiology, Institutional, Source Type: news

Breast implants tied to rare cancer to remain on US market
US will allow a type of breast implant linked to a rare form of cancer to stay on the market (Source: ABC News: Health)
Source: ABC News: Health - May 3, 2019 Category: Consumer Health News Tags: Health Source Type: news

Clinical Trials of New Cancer Drugs'Frequently Flawed'Clinical Trials of New Cancer Drugs'Frequently Flawed '
Many randomized clinical trials that lead to approvals for cancer drugs have suboptimal control arms, biasing outcomes in favor of the experimental arm.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Mayo Clinic Minute: Is alcohol the new smoking?
There is no question that smoking is bad for your health. It increases your risk of many diseases, including heart disease, lung disease and many cancers. Research in the journal BMC Public Health reports that drinking one bottle of wine per week equals that of five cigarettes per week for men or 10 cigarettes per [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 3, 2019 Category: Databases & Libraries Source Type: news

FDA allows sale of breast implant linked to cancer, strengthens warnings
Despite an outcry from women to ban a particular type of breast implant associated with a rare cancer, the sale of those implants will be allowed in the United States, the Food and Drug Administration announced Thursday. (Source: CNN.com - Health)
Source: CNN.com - Health - May 2, 2019 Category: Consumer Health News Source Type: news

Oregon oncologist hopes to offer broader access to new cancer therapy
CAR T cell therapy is a promising new gene therapy to treat cancer offered at a select few hospitals, including OHSU Hospital in Portland. Medicare is considering whether to cover the pricey therapy, which is given for two types of blood cancers. A Eugene oncologist is hoping Medicare will soon cover CAR-T in both the outpatient and in-patient settings. “The technology is evolving so quickly,” said Dr. Jeff Sharman, who also se rves as medical director of hematology research for the US Oncology… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 2, 2019 Category: American Health Authors: Elizabeth Hayes Source Type: news

Medical Costs Are Causing Financial Hardship For Americans, Study Finds
BOSTON (CBS) – A new study from the American Cancer Society finds that more than 137 million American adults reported financial hardship due to medical costs over the past year. Many patients pay out of pocket for medications, appointments, diagnostic tests and hospitalizations, which can lead to debt and financial stress. And as health care costs continue to rise and patients are increasingly asked to share the burden, the risk of hardship will likely increase. People without health insurance are hit the hardest, but so are younger adults, ages 18 to 64. The more people are asked to pay out of pocket, the more likel...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 2, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated Local American Cancer Society Dr. Mallika Marshall Source Type: news

Gilead tops earnings forecast as cancer drug drives sales
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 2, 2019 Category: Pharmaceuticals Source Type: news

Breast implants tied to cancer remain on U.S. market, under review by Health Canada
U.S. health authorities are allowing a type of breast implant with links to cancer to stay on the market. The same implant is under review by Health Canada. (Source: CBC | Health)
Source: CBC | Health - May 2, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

Men with serious illness may not seek erectile dysfunction treatment
(Reuters Health) - Men with cancer or other chronic illnesses are less likely to seek treatment for erectile dysfunction, even though sexual health is an important aspect of quality of life, researchers say. (Source: Reuters: Health)
Source: Reuters: Health - May 2, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Climate hysteria reaches peak insanity as NYC bans hot dogs, claiming they cause the planet to overheat
(Natural News) There are many reasons to avoid eating hot dogs: They’re loaded with salt and fat, often contain an array of controversial additives and are a potential carcinogen. Hot dogs are by no means a “health food,” but in New York City, they are a staple — or at least, they were. NYC liberals... (Source: NaturalNews.com)
Source: NaturalNews.com - May 2, 2019 Category: Consumer Health News Source Type: news

Amgen And Syapse Enter Precision Medicine Collaboration In Oncology
Supports Providers With Advanced Insight Tools and Research Opportunities Generates Insights From Real-World Evidence for Potential Use in Regulatory Filings THOUSAND OAKS, Calif. and SAN FRANCISCO, May 2, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN), a world leader in biotechnology, and Syapse, a company powering precision medicine insights through its global provider network, today announced a precision medicine collaboration in oncology. Under the terms of the agreement, Amgen and Syapse will develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology. This eff...
Source: Amgen News Release - May 2, 2019 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

F.D.A. Won ’ t Ban Sales of Textured Breast Implants Linked to Cancer
Many other countries have already banned the products. But the U.S. agency said the risk was still low, despite repeated requests from women and doctors that the implants be removed from the market. (Source: NYT Health)
Source: NYT Health - May 2, 2019 Category: Consumer Health News Authors: DENISE GRADY and RONI CARYN RABIN Tags: your-feed-science your-feed-healthcare Source Type: news

ASTRO: Prior Authorization Obstacles Delaying Treatment
THURSDAY, May 2, 2019 -- Prior authorization obstacles are delaying patient access to radiation oncology treatments, according to a survey released by the American Society for Radiation Oncology. A total of 620 radiation oncologists completed the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 2, 2019 Category: Pharmaceuticals Source Type: news

FDA: Breast Implants Linked to Cancer Can Still Be Sold in U.S.
THURSDAY, May 2, 2019 -- A type of breast implant linked to cancer can still be sold in the United States, the U.S. Food and Drug Administration said Thursday. The agency said it is too soon to ban a type of textured implant recently linked to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 2, 2019 Category: Pharmaceuticals Source Type: news

Red Tape May Delay Cancer Patients' Radiation
The delays cause added stress and anxiety for patients, and research has linked each week of delay in starting cancer therapy with a 1.2% to 3.2% increased risk of death, according to American Society for Radiation Oncology. (Source: WebMD Health)
Source: WebMD Health - May 2, 2019 Category: Consumer Health News Source Type: news

DNA Test Is an Effective Cervical Cancer Screening Tool for Women in Low-Income Countries
Effective cervical cancer screening initiative by Dartmouth researchers in Honduras identifies different human papillomavirus types than those in the U.S. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - May 2, 2019 Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Research cancer cervical cancer Gregory Tsongalis HPV Norris Cotton Cancer Center Source Type: news

New method quickly screens chemicals for cancer-causing potential
National Toxicology Program scientists, NIEHS grantees, and colleagues developed a quick way to screen substances for carcinogenicity. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - May 2, 2019 Category: Environmental Health Source Type: news

Spring GEMS meeting focuses on mechanisms
Risks of e-cigs and vaping, role of oxidative stress in cancer, and more were featured by the Genetics and Environmental Mutagenesis Society. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - May 2, 2019 Category: Environmental Health Source Type: news

FDA won’t ban breast implants linked to cancer at this time
A month after a dramatic hearing in which many women called on the Food and Drug Administration to ban a type of breast implant linked to a rare cancer, the agency said it won’t take that action now b... (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 2, 2019 Category: Consumer Health News Authors: Laurie McGinley Source Type: news

Time to Update & quot;Routine, Repeated & quot; Use of Bone Metastasis Drugs Time to Update & quot;Routine, Repeated & quot; Use of Bone Metastasis Drugs
Dr Mark Kris discusses the use of zoledronic acid and denosumab for preventing problems brought on by bone metastases.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Developing a Web-Based Cost Assessment Tool for Colorectal Cancer Screening Programs
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - May 2, 2019 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Red Tape Means Many Cancer Patients Get Radiation Treatments Late
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 2, 2019 Category: Cancer & Oncology Tags: Oncology, News, Source Type: news

Cervical Adenocarcinoma Rates Increased in Some Populations
Increasing and stabilizing incidence trends seen for several subpopulations; declines attenuated in SCC (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 2, 2019 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Journal, Source Type: news

Zap Surgical to defend against Elekta suit
Zap Surgical Systems said it would defend itself against a lawsuit filed by...Read more on AuntMinnie.comRelated Reading: Elekta sues Zap Surgical Systems Elekta gets Canadian clearance for Unity MR Elekta initiates study on MR radiation therapy for cancer Elekta reports 1st treatment at Froedtert Hospital FDA clears Elekta's Unity MR radiation therapy system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 2, 2019 Category: Radiology Source Type: news

ZAP Surgical Systems Responds to Elekta Lawsuit
SAN CARLOS, Calif., May 2, 2019 -- (Healthcare Sales & Marketing Network) -- On Friday, April 26, 2019, Elekta Ltd. and its US operating company Elekta, Inc. ("Elekta") filed a lawsuit against ZAP® Surgical Systems in the United States Distr... Devices, Oncology, Litigation ZAP Surgical Systems, Elekta, ZAP-X, Radiosurgery, Radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 2, 2019 Category: Pharmaceuticals Source Type: news

Bayer gets boost as EPA finds Monsanto ’s Roundup ‘safe’
Bayer got a boost in its ongoing defense of Monsanto ’s Roundup weedkiller with an Environmental Protection Agency report again affirming that glyphosate, the active ingredient in Roundup, is safe when properly used. “EPA continues to find that there are no risks to public health when glyphosate is used in accordance with its current label and t hat glyphosate is not a carcinogen,” the agency said in a report Tuesday. The EPA report follows two recent court verdicts against Bayer and Roundup.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 2, 2019 Category: Biotechnology Authors: Greg Edwards Source Type: news

Bayer gets boost as EPA finds Monsanto ’s Roundup ‘safe’
Bayer got a boost in its ongoing defense of Monsanto ’s Roundup weedkiller with an Environmental Protection Agency report again affirming that glyphosate, the active ingredient in Roundup, is safe when properly used. “EPA continues to find that there are no risks to public health when glyphosate is used in accordance with its current label and t hat glyphosate is not a carcinogen,” the agency said in a report Tuesday. The EPA report follows two recent court verdicts against Bayer and Roundup.… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 2, 2019 Category: Health Management Authors: Greg Edwards Source Type: news